Core Viewpoint - The news highlights the passing of Guan Ping, a prominent figure in the Chinese pharmaceutical industry, and acknowledges his significant contributions to the sector and various companies he worked with [2][4]. Group 1: Guan Ping's Contributions - Guan Ping was recognized as a senior professional manager in the Chinese pharmaceutical industry, earning accolades such as the "Top Ten Professional Managers" and "Top Ten Pharmaceutical Elites" [4]. - He played a pivotal role in the marketing of major OTC products like Calcium D and Bai Jia Hei, earning the title "Prince of OTC" for his achievements [4][5]. - His career began in 1988 at Xi'an Janssen, where he became the second local pharmaceutical representative, marking the start of his impactful journey in the industry [4]. Group 2: Career Milestones - A significant turning point in Guan Ping's career occurred in 1997 when he joined Wyeth as a regional marketing director, transitioning the company’s focus from hospital sales to the OTC retail market [4][5]. - Under his leadership, sales of Calcium D increased by nearly 20% in 1998, surpassing hospital sales in the retail market [5]. - In 2001, he joined Dongsheng Technology as a director and vice president, where he successfully revitalized the Bai Jia Hei brand, increasing its sales from over 2 million to more than 200 million [5][6]. Group 3: Innovative Strategies - Guan Ping introduced innovative marketing strategies, such as in-store competitions and training for pharmacy staff, which were unprecedented in the industry at the time [5]. - He recognized the challenges faced by pharmaceutical distributors due to shrinking profit margins and implemented a commission-based model in 2002 to enhance profitability for distributors [6]. - By 2004, the sales of the Dongsheng anti-cold family exceeded 50 million, with Bai Jia Hei achieving a record of 500 million [6].

Core Viewpoint - Yuanhe Pharmaceutical announced the unfortunate passing of its director, Mr. Guan Ping, on December 1, 2025, due to an accident, expressing deep condolences and gratitude for his contributions to the company [1][3]. Group 1: Company Information - Mr. Guan Ping held 500,000 shares of Yuanhe Pharmaceutical, representing 0.81% of the company's total equity [3]. - The company and its employees paid high respect and heartfelt thanks to Mr. Guan for his hard work and outstanding contributions during his tenure [3]. Group 2: Industry Background - Mr. Guan Ping was a seasoned professional in the Chinese pharmaceutical industry, recognized as one of the top ten professional managers and pharmaceutical elites, earning the nickname "Prince of OTC" for his significant contributions to the OTC market [5][6]. - His career included key positions at major pharmaceutical companies such as Xi'an Janssen, Lizhu Group, Wyeth, Shijiazhuang Pharmaceutical Group, and Dongsheng Technology, where he played a pivotal role in launching successful products like Calcium D and Bai Jia Hei [5][6][7]. - Mr. Guan's innovative marketing strategies, such as in-store promotions and training for pharmacy staff, significantly boosted sales, exemplified by the increase in sales of Calcium D by nearly 20% in 1998 [6][7].